Healthcare also saw a significant rise in Critical and High severities, revealing an 85.71% increase versus 2023, according to reporting findings. In May 2024, there were 51 data breaches in the U ...

The FDA has approved Otezla for the treatment of patients with plaque psoriasis of all severity levels, according to a company press release. The approval makes Otezla (apremilast, Amgen) the ...